v3.25.1
Revenue (Tables)
3 Months Ended
Mar. 31, 2025
Revenue from Contract with Customer [Abstract]  
Schedule of Net Sales Disaggregated By Channel

The following tables present product net sales disaggregated by Channel and Geographic Market (in thousands):

 

Channel:  2025   2024 
   Three months ended March 31, 
Channel:  2025   2024 
Rx gammaCore – VA  $4,721   $3,875 
Rx gammaCore - U.S. Commercial   289    433 
Outside the United States   513    449 
Truvaga   1,106    385 
Total before TAC-STIM   6,629    5,142 
TAC-STIM   90    301 
Total Net Sales  $6,719   $5,443 
Schedule of Net Slaes Disaggregated By Geographic Market

Product revenue  2025   2024 
Geographic Market:  Three months ended March 31, 
Product revenue  2025   2024 
United States  $6,206   $4,994 
United Kingdom   451    385 
Other   47    45 
License revenue          
Japan   15    19 
Total Net Sales  $6,719   $5,443